Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kenichiro Miyagawa is active.

Publication


Featured researches published by Kenichiro Miyagawa.


Antimicrobial Agents and Chemotherapy | 2001

In Vitro and In Vivo Antibacterial Activities of TAK-083, an Agent for Treatment of Helicobacter pylori Infection

Tsuneo Kanamaru; Yoshitaka Nakano; Yukio Toyoda; Kenichiro Miyagawa; Mayumi Tada; Tomoko Kaisho; Masafumi Nakao

ABSTRACT The antibacterial activity of TAK-083 was tested against 54 clinical isolates of Helicobacter pylori and was compared with those of amoxicillin, clarithromycin, and metronidazole. The growth-inhibitory activity of TAK-083 was more potent than that of amoxicillin, clarithromycin, or metronidazole (the MICs at which 90% of the strains are inhibited were 0.031, 0.125, 64, and 8 μg/ml, respectively). The antibacterial activity of TAK-083 was highly selective against H. pylori; there was a >30-fold difference between the concentration of TAK-083 required to inhibit the growth of H. pylori and that required to inhibit the growth of common aerobic and anaerobic bacteria. Exposure ofH. pylori strains to TAK-083 at the MIC or at a greater concentration resulted in an extensive loss of viability. When four H. pylori strains were successively subcultured in the medium containing subinhibitory concentrations of TAK-083, no significant change in the MICs of this compound was observed. TAK-083 strongly inhibited the formation of tryptophanyl-tRNA in H. pylori while exhibiting little effect on the same system in eukaryotes. TAK-083 was efficacious in the treatment of gastric infection caused by H. pylori in Mongolian gerbils. The results presented here indicate that TAK-083 is a promising candidate for the treatment of H. pylori infection.


Journal of Fermentation and Bioengineering | 1996

Trehalose Accumulation by a Basidiomycotinous Yeast, Filobasidium floriforme

Junichi Miyazaki; Kenichiro Miyagawa; Yoshio Sugiyama

Abstract Screening was performed to isolate microorganisms which accumulate trehalose. Of 96 yeast strains screened, a basidiomycotinous yeast, Filobasidium floriforme IFO 1916, accumulated the largest amount of trehalose. Under optimum conditions in a 5- l jar fermentor, F. floriforme IFO 1916 accumulated 10 mg/ml trehalose (dry cell weight, 52 mg/ml; trehalose content, 20.0%) from 100 mg/ml glucose after cultivation for 24 h. Strain T12, a morphological and trehalose non-assimilating mutant of F. floriforme IFO 1916, accumulated 30% more trehalose than the parent strain.


Agricultural and biological chemistry | 1979

Effect of Aspartic Acid Family Amino Acids on Production of Maridomycin III

Kenichiro Miyagawa; Masam Suzuki; Eiji Higashide; Minoru Uchida

An attempt was made to increase the production of maridomycin III (MDM III) as the major component among the six components of maridomycin (maridomycin I, II, III, IV, V and VI). Addition to the production medium, of amino acids belonging to the aspartic acid family and its related compounds, such as l-isoleucine, l-threonine, l-methionine, l-homoserine, dl-α-amino-n-butyric acid and α-ketobutyric acid, resulted in a yield of a large amount of MDM III.MDM III was also formed by intact cells from 4″-depropionyl MDM III and the same compounds. From 4″-depropionyl MDM III and l-isoleucine-U-14C (or dl-α-amino-n-butyric acid-3-14C), MDM III-14C was formed, and a large amount of radioactivity was incorporated into MDM III. On deacylation at C-4″ of the MDM III-14C, about 90% of radioactivity of MDM III-14C was observed as propionic acid-14CIn the same way, SF-837-14C was formed from leucomycin A7 and l-isoleucine-U-14C (or dl-α-amino-n-butyric acid-3-14C), and deacylation of the SF-837-14C at C–3 also gave pro...


Bioscience, Biotechnology, and Biochemistry | 1995

Purification and Characterization of Trehalose Phosphorylase from Micrococcus varians

Hideki Kizawa; Kenichiro Miyagawa; Yoshio Sugiyama


Nature Biotechnology | 1986

Cloning of the Bacillus Subtilis IMP Dehydrogenase Gene and its Application to Increased Production of Guanosine

Kenichiro Miyagawa; Hiroyuki Kimura; Kazuo Nakahama; Masakazu Kikuchi; Muneharu Doi; Shun-ichi Akiyama; Yoshio Nakao


Archive | 1984

Dna and its use

Kenichiro Miyagawa; Kazuo Nakahama; Masakazu Kikuchi; Muneharu Doi


The Journal of Antibiotics | 2002

Synthesis and anti-Helicobacter pylori activity of pyloricidin derivatives I. Structure-activity relationships on the terminal peptidic moiety.

Atsushi Hasuoka; Yuji Nishikimi; Yutaka Nakayama; Keiji Kamiyama; Masafumi Nakao; Kenichiro Miyagawa; Osamu Nishimura; Masahiko Fujino


The Journal of Antibiotics | 2001

Pyloricidins, Novel Anti-Helicobacter pylori Antibiotics Produced by Bacillus sp. : I. Taxonomy, Fermentation and Biological Activity

Masafumi Nakao; Kenichiro Miyagawa; Yoshitaka Nakano; Takeshi Sakane; Mayumi Tada; Osamu Nishimura; Masahiko Fujino


Bioscience, Biotechnology, and Biochemistry | 1995

Trehalose Production by a Strain of Micrococcus varians

Hideki Kizawa; Junichi Miyazaki; Akira Yokota; Yukihiro Kanegae; Kenichiro Miyagawa; Yoshio Sugiyama


Nature Biotechnology | 1989

Increased Inosine Production by a Bacillus subtilis Xanthine-Requiring Mutant Derived by Insertional Inactivation of the IMP Dehydrogenase Gene

Kenichiro Miyagawa; Naoyuki Kanzaki; Hiroyuki Kimura; Yasuhiro Sumino; Shun-ichi Akiyama; Yoshio Nakao

Collaboration


Dive into the Kenichiro Miyagawa's collaboration.

Top Co-Authors

Avatar

Masafumi Nakao

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Keiji Kamiyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Naoyuki Kanzaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yuji Nishikimi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Atsushi Hasuoka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Junichi Miyazaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Motoo Izawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshio Sugiyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masahiko Fujino

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge